Kathmere Capital Management’s iShares iBonds Dec 2021 Term Corporate ETF IBDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-21,250
Closed -$526K 152
2021
Q3
$526K Sell
21,250
-3,798
-15% -$94K 0.1% 67
2021
Q2
$621K Buy
25,048
+31
+0.1% +$769 0.12% 64
2021
Q1
$622K Sell
25,017
-16,350
-40% -$407K 0.12% 63
2020
Q4
$1.03M Sell
41,367
-5,192
-11% -$130K 0.22% 39
2020
Q3
$1.17M Buy
46,559
+183
+0.4% +$4.59K 0.29% 35
2020
Q2
$1.17M Buy
46,376
+208
+0.5% +$5.2K 0.34% 35
2020
Q1
$1.14M Buy
46,168
+8,632
+23% +$214K 0.41% 37
2019
Q4
$937K Buy
+37,536
New +$937K 0.33% 50

Other funds holding IBDM

Kathmere Capital Management's IBDM Position: Q4 2021 in Review

Kathmere Capital Management sold out of iShares iBonds Dec 2021 Term Corporate ETF (IBDM) in Q4 2021, closing a stake of 21,250 shares — an estimated $526K sold.

Kathmere Capital Management first reported a position in IBDM in Q4 2019 and held it in 8 quarters. The position peaked at $1.17M in Q3 2020. 1 fund tracked by Wall St. Rank holds IBDM as of Q4 2021.

  • Kathmere Capital Management reported no remaining iShares iBonds Dec 2021 Term Corporate ETF position as of Q4 2021 after selling out during the quarter.
  • Kathmere Capital Management sold 21,250 iShares iBonds Dec 2021 Term Corporate ETF shares in Q4 2021, an estimated $526K.
  • Kathmere Capital Management first reported a position in iShares iBonds Dec 2021 Term Corporate ETF in Q4 2019 and held it in 8 quarters.
  • Kathmere Capital Management's iShares iBonds Dec 2021 Term Corporate ETF position peaked at $1.17M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held iShares iBonds Dec 2021 Term Corporate ETF as of Q4 2021.

Based on Kathmere Capital Management's 13F filing for Q4 2021, filed 27 Jan 2022.